These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38900223)

  • 1. Misclassification of a frequent variant from PMS2CL pseudogene as a PMS2 loss of function variant in Brazilian patients.
    Segura AVC; da Silva SIO; Santiago KM; Brianese RC; Carraro DM; Torrezan GT
    Fam Cancer; 2024 Nov; 23(4):653-657. PubMed ID: 38900223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.
    Gould GM; Grauman PV; Theilmann MR; Spurka L; Wang IE; Melroy LM; Chin RG; Hite DH; Chu CS; Maguire JR; Hogan GJ; Muzzey D
    BMC Med Genet; 2018 Sep; 19(1):176. PubMed ID: 30268105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reclassification of a frequent African-origin variant from PMS2 to the pseudogene PMS2CL.
    Chong AS; Chong G; Foulkes WD; Saskin A
    Hum Mutat; 2020 Apr; 41(4):749-752. PubMed ID: 31916644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene.
    Bouras A; Lefol C; Ruano E; Grand-Masson C; Wang Q
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23193. PubMed ID: 37534630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.
    van der Klift HM; Tops CM; Bik EC; Boogaard MW; Borgstein AM; Hansson KB; Ausems MG; Gomez Garcia E; Green A; Hes FJ; Izatt L; van Hest LP; Alonso AM; Vriends AH; Wagner A; van Zelst-Stams WA; Vasen HF; Morreau H; Devilee P; Wijnen JT
    Hum Mutat; 2010 May; 31(5):578-87. PubMed ID: 20186688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pathogenic variants detected in high homology regions of the
    Paixão D; Lima THA; de Souza RRF; Carnavalli JEP; Picanço-Albuquerque CG; Silva-Fernandes IJL; de Barros Silva PG; Mitne-Neto M; Moreira CM; Baratela WADR
    Front Oncol; 2024; 14():1390221. PubMed ID: 38957325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
    Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
    Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant Detection in 3' Exons of PMS2 Using Exome Sequencing Data.
    Mistry NA; Roellinger SE; Manninen MC; Gandham M; Koganti T; Balan J; Basu S; Blake EJ; Tandale PP; Holdren MA; Hoenig MF; Urban RM; Veith RL; Kendzior MC; Wang C; Gupta S; Shen W
    J Mol Diagn; 2024 Sep; 26(9):843-850. PubMed ID: 38925456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pathogenic Variant Reclassified to the Pseudogene
    Fragoso-Ontiveros V; De la Fuente-Hernandez MA; Gonzalez-Osnaya V; Gamez-Rosales M; Perez-Montiel MD; Isla-Ortiz D; Cantu-De Leon DF; Alvarez-Gomez RM
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
    Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
    Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
    Wernstedt A; Valtorta E; Armelao F; Togni R; Girlando S; Baudis M; Heinimann K; Messiaen L; Staehli N; Zschocke J; Marra G; Wimmer K
    Genes Chromosomes Cancer; 2012 Sep; 51(9):819-31. PubMed ID: 22585707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.
    Nomura S; Fujimoto Y; Yamamoto N; Sato Y; Ashihara Y; Kita M; Yamaguchi J; Ishikawa Y; Ueno M; Arai M
    Jpn J Clin Oncol; 2015 Oct; 45(10):987-92. PubMed ID: 26232782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing landscape of Lynch syndrome due to PMS2 mutations.
    Blount J; Prakash A
    Clin Genet; 2018 Jul; 94(1):61-69. PubMed ID: 29286535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-Source Bioinformatic Pipeline to Improve PMS2 Genetic Testing Using Short-Read NGS Data.
    Munté E; Feliubadaló L; Del Valle J; González S; Ramos-Muntada M; Balmaña J; Ramon Y Cajal T; Tuset N; Llort G; Cadiñanos J; Brunet J; Capellá G; Lázaro C; Pineda M
    J Mol Diagn; 2024 Aug; 26(8):727-738. PubMed ID: 38851388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional PMS2 hybrid alleles containing a pseudogene-specific missense variant trace back to a single ancient intrachromosomal recombination event.
    Ganster C; Wernstedt A; Kehrer-Sawatzki H; Messiaen L; Schmidt K; Rahner N; Heinimann K; Fonatsch C; Zschocke J; Wimmer K
    Hum Mutat; 2010 May; 31(5):552-60. PubMed ID: 20186689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of heterozygous
    Wang Q; Leclerc J; Bougeard G; Olschwang S; Vasseur S; Cassinari K; Boidin D; Lefol C; Naïbo P; Frébourg T; Buisine MP; Baert-Desurmont S;
    J Med Genet; 2020 Jul; 57(7):487-499. PubMed ID: 31992580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of
    Okkels H; Lagerstedt-Robinsson K; Wikman FP; Hansen TVO; Lolas I; Lindberg LJ; Krarup HB
    Genet Test Mol Biomarkers; 2019 Sep; 23(9):688-695. PubMed ID: 31433215
    [No Abstract]   [Full Text] [Related]  

  • 18. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.
    Etzler J; Peyrl A; Zatkova A; Schildhaus HU; Ficek A; Merkelbach-Bruse S; Kratz CP; Attarbaschi A; Hainfellner JA; Yao S; Messiaen L; Slavc I; Wimmer K
    Hum Mutat; 2008 Feb; 29(2):299-305. PubMed ID: 18030674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.
    Rosty C; Clendenning M; Walsh MD; Eriksen SV; Southey MC; Winship IM; Macrae FA; Boussioutas A; Poplawski NK; Parry S; Arnold J; Young JP; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Potter JD; DeRycke M; Lindor NM; Thibodeau SN; Baron JA; Win AK; Hopper JL; Jenkins MA; Buchanan DD;
    BMJ Open; 2016 Feb; 6(2):e010293. PubMed ID: 26895986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.